Working Groups

CGC Working Groups create evidence-based reviews and practice considerations that positively impact the appropriate utilization and reimbursement of genomic testing in cancer. Through this work, they play a central role in advancing the Cancer Genomics Consortium’s mission to promote the highest standards in clinical genomics, support scientific innovation, and improve patient care.

In this forum, Working Groups bring together members from across our multidisciplinary community to collaborate, share expertise, and address emerging challenges in cancer genomics. By fostering teamwork, personal growth, professional development, and scientific achievement, these groups strengthen the collective knowledge base and help ensure that evolving genomic technologies are applied responsibly and effectively.

We are grateful to the Working Groups who have completed their projects, and we deeply appreciate the authors for their time, expertise, and dedication. Their contributions help drive the CGC mission forward and support the continued advancement of clinical cancer genomics.


Active CGC Working Groups

Clinical Implementation of Multimodal Liquid Biopsy Cancer Testing Working Group
Leader: Alyssa Parker and 
Shiva Sathyanarayana
CGC Board Liaison: Trevor Pugh

Clinical Utility of Genome Wide Copy Number Analysis for Melanocytic Lesion Diagnosis
Leaders: Anwar Iqbal and Ravindra Kohle
CGC Board Liaison: Anwar Iqbal

Creation and Maintenance of Disease-Specific Gene Lists to Aid in Cancer Genome Interpretation
Leaders: Beth Pitel and Xinjie Xu
CGC Board Liaison: Trevor Pugh

Breast Cancer Working Group
Leaders: Hui Chen and Katherin Geiersbach
CGC Board Liaison: Adam Smith

Molecular Cancer Testing in Underserved Communities Working Group
Leader: Thuy Phung
CGC Board Liaison: Niroshi Senaratne

Macrogenomic Event Detection in Solid Tumors Working Group
Leader: Lisa Lansdon
CGC Board Liaison: Trevor Pugh

Somatic Overgrowth and Vascular Anomalies Working Group
Leaders: Avinash Dharmadhikari and Yang Cao
CGC Board Liaison: Cate Paschal